Amersham appoints exec

Article

James E. Rothman has been appointed to the newly created position of chief scientific adviser at Amersham. He has served seven years on the company's scientific advisory board. Rothman will work with CEO William Castell and will sit on Amersham's

James E. Rothman has been appointed to the newly created position of chief scientific adviser at Amersham. He has served seven years on the company's scientific advisory board. Rothman will work with CEO William Castell and will sit on Amersham's Portfolio Committee, which has primary responsibility for recommending overall strategic direction of the company's research.

Related Videos
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2023 MJH Life Sciences

All rights reserved.